Effect of PRM-125 on Ambulatory Blood Pressure
NCT05195827 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2023-03-20
Summary
Evaluation of Once-Daily PRM125 On Ambulatory Blood Pressure in Adults with Hypertension
Conditions
Interventions
- DRUG
-
PRM-125
Antihypertensive
Sponsors & Collaborators
-
PRM Pharma, LLC
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 30 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-20
- Primary Completion
- 2022-09-30
- Completion
- 2022-11-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Effect and Safety of Marealis RPC (Refined Peptide Concentrate) in Mild or Moderate Hypertensive Subjects
NCT01974570 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective Survey for Patients With Hypertension and Diabetes Mellitus
NCT00681278 ·Status: COMPLETED
-
Mechanism of Masked Hypertension - Intervention
NCT04121299 ·Status: WITHDRAWN ·Phase: PHASE3
-
Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension
NCT00684489 ·Status: COMPLETED ·Phase: NA
-
Effects of Antihypertensive Drug Treatment on Brain Blood Flow, Cognition, and Regulation of Nervous System in Older Adults With Hypertension.
NCT06287580 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Blood Pressure Reduction in Heart Failure
NCT01255475 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Assess the Safety, Tolerability, and Pharmacokinetics of REGN5381 (an NPR1 Agonist) in Adult Humans
NCT04506645 ·Status: COMPLETED ·Phase: PHASE1
-
Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure
NCT02591173 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Long-term of Remote Ischemic Preconditioning and Mindfulness in Patients With Mild Hypertension
NCT04753840 ·Status: RECRUITING ·Phase: NA
-
Improving Outcomes for Hypertensive Children
NCT01485783 ·Status: COMPLETED
-
Pharmacogenomic Evaluation of Antihypertensive Responses 2
NCT01203852 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
NCT05529147 ·Status: COMPLETED
-
Retrospective Treatment Pattern Survey for the Patients With Hypertension and Stroke
NCT00681707 ·Status: COMPLETED
-
Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN)
NCT05275907 ·Status: WITHDRAWN ·Phase: PHASE4
-
Intermittent Hypoxia 2: Cardiovascular and Metabolism
NCT02058823 ·Status: TERMINATED ·Phase: PHASE4
-
Hypertension Prevention in Pre-Hypertensive Individuals
NCT00970931 ·Status: COMPLETED ·Phase: PHASE3
-
REGN5381 in Adult Participants With Uncontrolled Hypertension
NCT06833190 ·Status: TERMINATED ·Phase: PHASE2
-
Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension
NCT02525926 ·Status: TERMINATED ·Phase: NA
-
Multi-center Study on New Cardiovascular Remodeling and Function Parameters in Hypertension
NCT05638503 ·Status: RECRUITING
-
MANP in African Americans With Hypertension
NCT04542681 ·Status: WITHDRAWN ·Phase: PHASE1
-
Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure
NCT00925470 ·Status: COMPLETED
-
Study of Amiloride on Vascular Phenotypes in Young Adults With Prehypertension
NCT01308983 ·Status: UNKNOWN ·Phase: PHASE4
-
Vascular Responses to Sympathetic Activation and Altered Shear Rate: The Impact of Hypertension and Sodium Intake
NCT03558022 ·Status: COMPLETED ·Phase: NA
-
Mechanisms of Refractory Hypertension (High and Low Salt Diet)
NCT02357017 ·Status: WITHDRAWN ·Phase: NA
-
Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular Health
NCT02972619 ·Status: UNKNOWN ·Phase: NA